MENU
TELO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Telomir Pharmaceuticals (TELO) Ownership - Who owns Telomir Pharmaceuticals?

Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science... Show more

Profile

Industry
N/A
Address
855 N Wolfe Street
Phone
+1 737 289-0835
Employees
9
Web
https://www.telomirpharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
48.82M
P/E Ratio
N/A
Total Cash
7.33M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.21
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

TELO
Capitalization
48.8M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
7.33M
Total Cash/Share
0.21
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
6.98M
P/B Ratio
6.99
Cash Flow
N/A
Earnings
-0.37
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
17.51
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-11.25M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-266.47
Shares Held By Institutions
5.23M
Shares Outstanding - Current
34.4M
Total Liabilities
423K
Total Volume MTD
N/A
Value
-1
Gain YTD
-65.534
View a ticker or compare two or three
TELO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TELO showed earnings on December 03, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
855 N Wolfe Street
Phone
+1 737 289-0835
Employees
9
Web
https://www.telomirpharma.com